Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial-Reference-Cited by-同舟云学术

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

Published:2007-06 Issue:6 Volume:8 Page:475-487
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Dearnaley David P,Sydes Matthew R,Graham John D,Aird Edwin G,Bottomley David,Cowan Richard A,Huddart Robert A,Jose Chakiath C,Matthews John HL,Millar Jeremy,Moore A Rollo,Morgan Rachel C,Russell J Martin,Scrase Christopher D,Stephens Richard J,Syndikus Isabel,Parmar Mahesh KB

Publisher

Elsevier BV

Subject

Oncology

Reference50 articles.

1. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000;Shibuya;BMC Cancer,2002

2. Active surveillance: towards a new paradigm in the management of early prostate cancer;Parker;Lancet Oncol,2004

3. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate pancer;D'Amico;JAMA,1998

4. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy;Peeters;J Clin Oncol,2006

5. A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy;Chism;Int J Radiat Oncol Biol Phys,2004

Cited by 809 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Volumetric Modulated Arc Therapy for High-Risk and Very High-Risk Locoregional Prostate Cancer in the Modern Era: Real-World Experience from an Asian Cohort;Cancers;2024-08-25

2. Protocol-based CT-guided brachytherapy for patients with prostate cancer and previous rectal extirpation—a curative approach;Strahlentherapie und Onkologie;2024-08-02

3. Tolérance à court et moyen terme d’une radiothérapie prostatique hypofractionnée selon la technique du boost intégré;Cancer/Radiothérapie;2024-08

4. Clinical and Dosimetric Comparison between Non-Image-Guided Radiation Therapy and Fiducial-Based Image-Guided Radiation Therapy with or without Reduced Margin in Intensity-Modulated Radiation Therapy for Prostate Cancer;Advances in Radiation Oncology;2024-08

5. Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate–High-Risk Prostate Cancer: Insights from a Phase I/II Study;Cancers;2024-05-31